GeneDx Holdings Corp. Increase (Decrease) in Accounts Payable and Accrued Liabilities
GeneDx Holdings Corp. (WGS) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$12.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-03
- GeneDx Holdings Corp. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $602.00K.
- GeneDx Holdings Corp. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$13.17M, a 221.66% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $6.92M.
- GeneDx Holdings Corp. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$2.01M, a 165.73% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $12.10M.
- GeneDx Holdings Corp. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$20.52M.
- GeneDx Holdings Corp. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$49.17M, a 242.68% decline from fiscal 2022.
- GeneDx Holdings Corp. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $34.46M, a 32.96% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $602.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$12.57M 10-Q · filed 2026-08-03 | -$5.65M derived: sum of 3 quarters · filed 2026-08-03 | -$7.67M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | -$13.17M 10-Q · filed 2026-05-04 | -$6.25M derived: sum of 2 quarters · filed 2026-05-04 | -$8.27M derived: sum of 3 quarters · filed 2026-05-04 | -$11.89M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $4.90M derived: sum of 2 quarters · filed 2026-02-23 | $1.28M derived: sum of 3 quarters · filed 2026-08-03 | $12.10M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$5.64M derived: sum of 2 quarters · filed 2026-08-03 | $5.18M 10-Q · filed 2025-10-28 | -$7.53M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | -$3.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $7.20M 10-Q · filed 2026-08-03 | -$5.52M derived: sum of 3 quarters · filed 2026-08-03 | -$2.45M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | $10.82M 10-Q · filed 2026-05-04 | -$1.89M derived: sum of 2 quarters · filed 2026-05-04 | $1.17M derived: sum of 3 quarters · filed 2026-05-04 | -$4.97M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | -$12.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$9.65M derived: sum of 2 quarters · filed 2026-02-23 | -$15.79M derived: sum of 3 quarters · filed 2026-02-23 | -$20.52M 10-K · filed 2026-02-23 | -$20.46M 10-K · filed 2025-02-20 | |||
| 2024-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$3.07M derived: sum of 2 quarters · filed 2025-10-28 | -$7.81M 10-Q · filed 2025-10-28 | -$17.06M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | -$6.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$10.87M 10-Q · filed 2025-07-29 | -$10.36M 10-Q · filed 2024-07-30 | -$20.13M derived: sum of 3 quarters · filed 2026-02-23 | -$34.64M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-03-31 | -$4.73M 10-Q · filed 2025-04-30 | -$13.99M derived: sum of 2 quarters · filed 2026-02-23 | -$28.50M derived: sum of 3 quarters · filed 2026-02-23 | -$40.50M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | -$9.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$23.77M derived: sum of 2 quarters · filed 2026-02-23 | -$35.77M derived: sum of 3 quarters · filed 2026-02-23 | -$49.17M 10-K · filed 2026-02-23 | -$46.95M 10-K · filed 2024-02-23 | |||
| 2023-09-30 | -$14.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$26.51M derived: sum of 2 quarters · filed 2024-10-29 | -$39.91M 10-Q · filed 2024-10-29 | -$34.01M derived: sum of 4 quarters · filed 2024-10-29 | ||||
| 2023-06-30 | -$12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$25.40M 10-Q · filed 2024-07-30 | -$19.50M derived: sum of 3 quarters · filed 2024-07-30 | -$26.65M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2023-03-31 | -$13.40M 10-Q · filed 2024-04-29 | -$14.47M 10-Q · filed 2023-05-09 | -$7.50M derived: sum of 2 quarters · filed 2024-04-29 | -$14.65M derived: sum of 3 quarters · filed 2024-04-29 | $17.13M derived: sum of 4 quarters · filed 2024-04-29 | |||
| 2022-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$1.25M derived: sum of 2 quarters · filed 2024-02-23 | $30.53M derived: sum of 3 quarters · filed 2024-02-23 | $34.46M 10-K · filed 2024-02-23 | ||||
| 2022-09-30 | -$7.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $24.63M derived: sum of 2 quarters · filed 2023-11-03 | $28.56M 10-Q · filed 2023-11-03 | $49.55M derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | $31.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $35.71M 10-Q · filed 2023-08-08 | $56.70M derived: sum of 3 quarters · filed 2023-08-08 | $51.60M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $3.93M 10-Q · filed 2023-05-09 | $24.92M derived: sum of 2 quarters · filed 2023-05-09 | $19.82M derived: sum of 3 quarters · filed 2023-05-09 | $25.90M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $20.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $15.89M derived: sum of 2 quarters · filed 2023-03-16 | $21.96M derived: sum of 3 quarters · filed 2023-03-16 | $25.92M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | -$5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $976.00K derived: sum of 2 quarters · filed 2022-11-14 | $4.93M 10-Q · filed 2022-11-14 | $4.68M 10-Q · filed 2021-11-15 | $20.27M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-06-30 | $6.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $10.03M 10-Q · filed 2022-08-15 | $25.37M derived: sum of 3 quarters · filed 2023-03-16 | |||||
| 2021-03-31 | $3.95M 10-Q · filed 2022-05-12 | $19.29M derived: sum of 2 quarters · filed 2023-03-16 | ||||||
| 2020-12-31 | $15.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $14.80M 10-K · filed 2023-03-16 | ||||||
| 2020-09-30 | -$537.00K 10-Q · filed 2021-11-15 | |||||||
| 2019-12-31 | $12.85M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |